| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epithelial Cells | 12 | 2020 | 366 | 3.360 |
Why?
|
| Intestinal Mucosa | 9 | 2019 | 115 | 3.050 |
Why?
|
| Mucous Membrane | 6 | 2020 | 34 | 2.620 |
Why?
|
| Peyer's Patches | 9 | 2017 | 15 | 2.580 |
Why?
|
| Staphylococcus aureus | 4 | 2020 | 80 | 1.830 |
Why?
|
| Vaccines | 4 | 2015 | 49 | 1.570 |
Why?
|
| Immunity, Mucosal | 5 | 2017 | 45 | 1.560 |
Why?
|
| Lung | 2 | 2023 | 413 | 1.440 |
Why?
|
| Staphylococcal Infections | 2 | 2020 | 64 | 1.400 |
Why?
|
| Mice | 34 | 2023 | 5668 | 1.340 |
Why?
|
| Lymphoid Tissue | 4 | 2020 | 17 | 1.320 |
Why?
|
| Membrane Proteins | 6 | 2012 | 486 | 1.270 |
Why?
|
| Flagellin | 2 | 2019 | 16 | 1.260 |
Why?
|
| Animals | 45 | 2023 | 14307 | 1.190 |
Why?
|
| Immunologic Surveillance | 3 | 2019 | 5 | 1.130 |
Why?
|
| Drug Delivery Systems | 3 | 2012 | 182 | 1.120 |
Why?
|
| Colitis | 2 | 2017 | 64 | 1.110 |
Why?
|
| Bacterial Proteins | 3 | 2020 | 520 | 1.060 |
Why?
|
| Lymphotoxin beta Receptor | 3 | 2017 | 5 | 0.990 |
Why?
|
| Pneumonia | 2 | 2018 | 50 | 0.940 |
Why?
|
| Inflammation | 4 | 2021 | 577 | 0.910 |
Why?
|
| Ileitis | 1 | 2022 | 2 | 0.890 |
Why?
|
| Epithelium | 3 | 2019 | 74 | 0.860 |
Why?
|
| Wound Healing | 2 | 2013 | 69 | 0.860 |
Why?
|
| Adhesins, Bacterial | 2 | 2020 | 18 | 0.840 |
Why?
|
| Crohn Disease | 1 | 2022 | 55 | 0.830 |
Why?
|
| Allergens | 2 | 2021 | 58 | 0.810 |
Why?
|
| Dust | 1 | 2021 | 51 | 0.780 |
Why?
|
| Microvilli | 3 | 2016 | 9 | 0.740 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2009 | 32 | 0.710 |
Why?
|
| Salmonella typhimurium | 1 | 2019 | 40 | 0.700 |
Why?
|
| Flagella | 1 | 2019 | 29 | 0.700 |
Why?
|
| Nanoparticles | 5 | 2020 | 294 | 0.680 |
Why?
|
| Bacterial Adhesion | 2 | 2020 | 36 | 0.680 |
Why?
|
| Immunity, Innate | 2 | 2018 | 135 | 0.650 |
Why?
|
| Bacterial Vaccines | 1 | 2019 | 122 | 0.650 |
Why?
|
| Brain Stem | 1 | 2018 | 46 | 0.630 |
Why?
|
| Carrier Proteins | 3 | 2011 | 287 | 0.630 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 12 | 0.620 |
Why?
|
| Peptides | 2 | 2012 | 308 | 0.620 |
Why?
|
| Mice, Inbred BALB C | 9 | 2016 | 649 | 0.610 |
Why?
|
| Fungi | 1 | 2018 | 86 | 0.590 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 89 | 0.590 |
Why?
|
| Static Electricity | 2 | 2014 | 75 | 0.580 |
Why?
|
| Bone Regeneration | 2 | 2012 | 4 | 0.570 |
Why?
|
| Dendritic Cells | 9 | 2019 | 112 | 0.560 |
Why?
|
| Polyglycolic Acid | 3 | 2011 | 35 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 1530 | 0.540 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2022 | 325 | 0.540 |
Why?
|
| Lactic Acid | 3 | 2011 | 87 | 0.530 |
Why?
|
| Epitopes | 1 | 2015 | 145 | 0.520 |
Why?
|
| Viral Envelope Proteins | 1 | 2015 | 77 | 0.510 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2014 | 2 | 0.500 |
Why?
|
| Cell Lineage | 3 | 2015 | 88 | 0.490 |
Why?
|
| Endocytosis | 2 | 2019 | 104 | 0.490 |
Why?
|
| Vaccination | 2 | 2012 | 259 | 0.480 |
Why?
|
| Administration, Intranasal | 2 | 2012 | 77 | 0.480 |
Why?
|
| Ligands | 3 | 2016 | 317 | 0.470 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 10 | 0.460 |
Why?
|
| Craniotomy | 1 | 2013 | 4 | 0.460 |
Why?
|
| Parietal Bone | 1 | 2012 | 1 | 0.460 |
Why?
|
| Osteotomy | 1 | 2012 | 4 | 0.450 |
Why?
|
| Lasers, Solid-State | 1 | 2012 | 13 | 0.450 |
Why?
|
| Chemokine CCL21 | 2 | 2010 | 11 | 0.450 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2016 | 138 | 0.440 |
Why?
|
| Aerosols | 2 | 2023 | 48 | 0.440 |
Why?
|
| Nanotechnology | 2 | 2011 | 150 | 0.440 |
Why?
|
| Claudins | 1 | 2012 | 8 | 0.430 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 16 | 0.430 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2010 | 251 | 0.430 |
Why?
|
| Immunoglobulin A | 1 | 2012 | 58 | 0.420 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 72 | 0.420 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 29 | 0.420 |
Why?
|
| Particle Size | 4 | 2023 | 200 | 0.410 |
Why?
|
| Humans | 25 | 2020 | 34853 | 0.400 |
Why?
|
| Signal Transduction | 4 | 2017 | 1802 | 0.400 |
Why?
|
| Transport Vesicles | 1 | 2011 | 20 | 0.390 |
Why?
|
| Enterotoxins | 1 | 2011 | 32 | 0.390 |
Why?
|
| Poloxamer | 1 | 2010 | 9 | 0.380 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2022 | 21 | 0.380 |
Why?
|
| Ions | 1 | 2010 | 61 | 0.370 |
Why?
|
| Hemagglutinins | 1 | 2009 | 8 | 0.370 |
Why?
|
| Lymphotoxin-beta | 2 | 2009 | 3 | 0.370 |
Why?
|
| Cell Differentiation | 8 | 2017 | 562 | 0.360 |
Why?
|
| Antigen-Presenting Cells | 3 | 2012 | 30 | 0.360 |
Why?
|
| Chemokine CCL19 | 1 | 2009 | 5 | 0.350 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2009 | 15 | 0.350 |
Why?
|
| Clostridium perfringens | 1 | 2008 | 3 | 0.340 |
Why?
|
| Enterobacteriaceae | 1 | 2009 | 26 | 0.340 |
Why?
|
| Endotoxins | 1 | 2008 | 18 | 0.340 |
Why?
|
| Biofilms | 2 | 2020 | 166 | 0.330 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 59 | 0.330 |
Why?
|
| Models, Immunological | 1 | 2008 | 20 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2008 | 150 | 0.310 |
Why?
|
| Mice, Knockout | 8 | 2018 | 897 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 206 | 0.310 |
Why?
|
| Neuroimmunomodulation | 1 | 2007 | 13 | 0.300 |
Why?
|
| Dextran Sulfate | 2 | 2017 | 14 | 0.300 |
Why?
|
| Immune System | 1 | 2007 | 40 | 0.300 |
Why?
|
| Up-Regulation | 1 | 2009 | 490 | 0.290 |
Why?
|
| Immunity | 2 | 2020 | 51 | 0.290 |
Why?
|
| Homeostasis | 1 | 2008 | 172 | 0.290 |
Why?
|
| Central Nervous System | 1 | 2007 | 130 | 0.280 |
Why?
|
| Colon | 2 | 2017 | 98 | 0.280 |
Why?
|
| Cell Line | 4 | 2010 | 1289 | 0.270 |
Why?
|
| Mice, Transgenic | 6 | 2016 | 608 | 0.270 |
Why?
|
| Flow Cytometry | 4 | 2013 | 392 | 0.260 |
Why?
|
| Drug Carriers | 2 | 2020 | 121 | 0.260 |
Why?
|
| Caco-2 Cells | 3 | 2010 | 48 | 0.240 |
Why?
|
| Administration, Inhalation | 1 | 2023 | 75 | 0.240 |
Why?
|
| Protein Binding | 3 | 2020 | 913 | 0.240 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 136 | 0.230 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 1300 | 0.230 |
Why?
|
| Regeneration | 2 | 2013 | 20 | 0.230 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1149 | 0.220 |
Why?
|
| Bacteria | 2 | 2019 | 245 | 0.220 |
Why?
|
| B-Lymphocytes | 2 | 2015 | 181 | 0.210 |
Why?
|
| Cytokines | 3 | 2020 | 569 | 0.210 |
Why?
|
| Cloning, Molecular | 2 | 2014 | 310 | 0.210 |
Why?
|
| Surface Plasmon Resonance | 3 | 2011 | 20 | 0.210 |
Why?
|
| Mammals | 1 | 2022 | 96 | 0.210 |
Why?
|
| Stem Cells | 2 | 2013 | 132 | 0.210 |
Why?
|
| Adipose Tissue | 2 | 2013 | 167 | 0.200 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 48 | 0.200 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 14 | 0.200 |
Why?
|
| Transcription Factor RelB | 4 | 2009 | 8 | 0.190 |
Why?
|
| Phototherapy | 1 | 2020 | 19 | 0.190 |
Why?
|
| Disease Progression | 1 | 2022 | 580 | 0.180 |
Why?
|
| Erythrocytes | 1 | 2020 | 107 | 0.180 |
Why?
|
| Cross-Linking Reagents | 1 | 2019 | 48 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2012 | 286 | 0.180 |
Why?
|
| Lymphocytes | 1 | 2020 | 116 | 0.170 |
Why?
|
| Cricetulus | 2 | 2009 | 74 | 0.170 |
Why?
|
| CHO Cells | 2 | 2009 | 107 | 0.170 |
Why?
|
| T-Lymphocytes | 3 | 2015 | 341 | 0.170 |
Why?
|
| Disulfides | 1 | 2019 | 77 | 0.170 |
Why?
|
| Cricetinae | 2 | 2009 | 217 | 0.170 |
Why?
|
| DNA Primers | 3 | 2011 | 269 | 0.170 |
Why?
|
| Protein Multimerization | 1 | 2019 | 97 | 0.170 |
Why?
|
| Phenotype | 2 | 2019 | 650 | 0.160 |
Why?
|
| Air Pollution | 1 | 2019 | 59 | 0.160 |
Why?
|
| Protein Conformation | 1 | 2019 | 350 | 0.160 |
Why?
|
| Arginase | 1 | 2018 | 12 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 85 | 0.160 |
Why?
|
| Cells, Cultured | 7 | 2018 | 1442 | 0.160 |
Why?
|
| Strongylida Infections | 1 | 2018 | 22 | 0.160 |
Why?
|
| Inhalation Exposure | 1 | 2018 | 37 | 0.160 |
Why?
|
| Adjuvants, Immunologic | 2 | 2012 | 106 | 0.160 |
Why?
|
| Immunomodulation | 1 | 2017 | 13 | 0.160 |
Why?
|
| RNA, Messenger | 2 | 2018 | 1152 | 0.160 |
Why?
|
| Models, Molecular | 2 | 2019 | 751 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 91 | 0.160 |
Why?
|
| Environmental Monitoring | 1 | 2019 | 188 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2018 | 116 | 0.150 |
Why?
|
| RANK Ligand | 1 | 2017 | 13 | 0.150 |
Why?
|
| Models, Animal | 2 | 2020 | 131 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 355 | 0.150 |
Why?
|
| Interleukin-6 | 1 | 2018 | 140 | 0.150 |
Why?
|
| Receptors, CCR7 | 1 | 2016 | 11 | 0.150 |
Why?
|
| Citrobacter rodentium | 1 | 2016 | 1 | 0.140 |
Why?
|
| Irritants | 1 | 2016 | 8 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2013 | 31 | 0.140 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2016 | 11 | 0.140 |
Why?
|
| Salmonella enterica | 1 | 2015 | 8 | 0.140 |
Why?
|
| Receptors, Chemokine | 1 | 2016 | 68 | 0.140 |
Why?
|
| Tissue Engineering | 2 | 2013 | 59 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2015 | 40 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 117 | 0.130 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 2128 | 0.130 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 81 | 0.130 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 54 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2015 | 89 | 0.120 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 232 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2020 | 200 | 0.120 |
Why?
|
| Surface Properties | 1 | 2014 | 121 | 0.120 |
Why?
|
| Ovalbumin | 3 | 2009 | 43 | 0.120 |
Why?
|
| Crosses, Genetic | 2 | 2015 | 48 | 0.120 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 485 | 0.120 |
Why?
|
| Gene Expression | 2 | 2009 | 639 | 0.120 |
Why?
|
| Tissue Survival | 1 | 2013 | 3 | 0.110 |
Why?
|
| Cranial Sutures | 1 | 2012 | 1 | 0.110 |
Why?
|
| Pierre Robin Syndrome | 1 | 2012 | 1 | 0.110 |
Why?
|
| Mandibulofacial Dysostosis | 1 | 2012 | 2 | 0.110 |
Why?
|
| Mandible | 1 | 2012 | 15 | 0.110 |
Why?
|
| Cephalometry | 1 | 2012 | 24 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 31 | 0.110 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 119 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 31 | 0.110 |
Why?
|
| Monitoring, Immunologic | 1 | 2012 | 1 | 0.110 |
Why?
|
| Goblet Cells | 1 | 2012 | 11 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2009 | 600 | 0.110 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2012 | 15 | 0.110 |
Why?
|
| Nanocapsules | 1 | 2012 | 16 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 605 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 125 | 0.110 |
Why?
|
| Immunization | 1 | 2012 | 90 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 89 | 0.110 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 14 | 0.110 |
Why?
|
| Models, Biological | 2 | 2012 | 642 | 0.100 |
Why?
|
| Complement C3 | 1 | 2011 | 15 | 0.100 |
Why?
|
| Complement Activation | 1 | 2011 | 13 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2011 | 132 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2012 | 50 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 484 | 0.100 |
Why?
|
| Polymers | 1 | 2012 | 117 | 0.100 |
Why?
|
| Microglia | 2 | 2010 | 152 | 0.100 |
Why?
|
| Histocytochemistry | 1 | 2011 | 45 | 0.100 |
Why?
|
| Peptides, Cyclic | 1 | 2011 | 30 | 0.100 |
Why?
|
| Toxoplasma | 1 | 2010 | 8 | 0.100 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2010 | 9 | 0.100 |
Why?
|
| Cell Count | 2 | 2008 | 129 | 0.100 |
Why?
|
| Nasopharynx | 1 | 2010 | 6 | 0.100 |
Why?
|
| Buffers | 1 | 2010 | 16 | 0.100 |
Why?
|
| Kinetics | 1 | 2012 | 650 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 200 | 0.090 |
Why?
|
| Otitis Media | 1 | 2009 | 2 | 0.090 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2009 | 5 | 0.090 |
Why?
|
| Streptolysins | 1 | 2009 | 4 | 0.090 |
Why?
|
| Influenza A virus | 1 | 2009 | 25 | 0.090 |
Why?
|
| Neuroendocrine Secretory Protein 7B2 | 1 | 2009 | 1 | 0.090 |
Why?
|
| Chemokine CCL20 | 1 | 2009 | 7 | 0.090 |
Why?
|
| Annexin A5 | 1 | 2009 | 24 | 0.090 |
Why?
|
| Streptococcus pneumoniae | 1 | 2009 | 28 | 0.090 |
Why?
|
| Lipoproteins | 1 | 2009 | 61 | 0.090 |
Why?
|
| Biological Transport | 1 | 2009 | 175 | 0.090 |
Why?
|
| Genes, Bacterial | 1 | 2009 | 88 | 0.090 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2009 | 10 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 78 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2009 | 64 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 70 | 0.090 |
Why?
|
| Macrophage Activation | 1 | 2009 | 52 | 0.090 |
Why?
|
| Hemagglutinins, Viral | 1 | 2008 | 1 | 0.090 |
Why?
|
| Tissue Scaffolds | 3 | 2013 | 24 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 85 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2009 | 135 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 143 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 210 | 0.080 |
Why?
|
| Protein Transport | 1 | 2009 | 286 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 2009 | 235 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 197 | 0.080 |
Why?
|
| Macrophages | 2 | 2009 | 431 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 282 | 0.080 |
Why?
|
| Male | 5 | 2018 | 18870 | 0.080 |
Why?
|
| Spleen | 3 | 2020 | 192 | 0.080 |
Why?
|
| Cross-Priming | 1 | 2006 | 1 | 0.070 |
Why?
|
| Interferon-alpha | 1 | 2006 | 37 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2003 | 54 | 0.070 |
Why?
|
| Female | 5 | 2020 | 19873 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2007 | 119 | 0.070 |
Why?
|
| Cell Survival | 3 | 2013 | 818 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 229 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 57 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2003 | 29 | 0.060 |
Why?
|
| Autoantigens | 1 | 2004 | 82 | 0.060 |
Why?
|
| Plant Lectins | 1 | 2003 | 4 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2003 | 12 | 0.060 |
Why?
|
| Th1 Cells | 1 | 2003 | 87 | 0.060 |
Why?
|
| Dermatitis | 1 | 2003 | 8 | 0.060 |
Why?
|
| Species Specificity | 1 | 2004 | 233 | 0.060 |
Why?
|
| Laminin | 1 | 2003 | 59 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 165 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2003 | 175 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 84 | 0.060 |
Why?
|
| Skull | 2 | 2013 | 35 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2003 | 55 | 0.060 |
Why?
|
| Keratinocytes | 1 | 2003 | 65 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 86 | 0.060 |
Why?
|
| PrPSc Proteins | 1 | 2002 | 2 | 0.050 |
Why?
|
| Scrapie | 1 | 2002 | 14 | 0.050 |
Why?
|
| Lymphotoxin-alpha | 1 | 2002 | 5 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2013 | 323 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 3261 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 859 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2003 | 653 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2020 | 23 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2020 | 58 | 0.050 |
Why?
|
| Infrared Rays | 1 | 2020 | 18 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 968 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 145 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2010 | 139 | 0.050 |
Why?
|
| Industrial Waste | 1 | 2019 | 16 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2019 | 33 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 528 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 127 | 0.040 |
Why?
|
| Nippostrongylus | 1 | 2018 | 1 | 0.040 |
Why?
|
| Radiation Chimera | 1 | 2018 | 7 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 465 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2018 | 31 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 182 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2018 | 56 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2018 | 96 | 0.040 |
Why?
|
| Liver | 1 | 2020 | 447 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2018 | 209 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 180 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2016 | 22 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2016 | 119 | 0.040 |
Why?
|
| Chimera | 2 | 2006 | 15 | 0.030 |
Why?
|
| Cartilage | 1 | 2015 | 18 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2015 | 22 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2012 | 12 | 0.030 |
Why?
|
| Chin | 1 | 2012 | 5 | 0.030 |
Why?
|
| Craniosynostoses | 1 | 2012 | 3 | 0.030 |
Why?
|
| Mandibular Condyle | 1 | 2012 | 6 | 0.030 |
Why?
|
| Cell Size | 1 | 2013 | 42 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 9 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2013 | 45 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 48 | 0.030 |
Why?
|
| Teratoma | 1 | 2012 | 8 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2012 | 14 | 0.030 |
Why?
|
| Regenerative Medicine | 1 | 2012 | 11 | 0.030 |
Why?
|
| Biology | 1 | 2012 | 15 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 87 | 0.030 |
Why?
|
| Organ Size | 1 | 2013 | 148 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2013 | 100 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 36 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2013 | 70 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 57 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 164 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 21 | 0.020 |
Why?
|
| Drug Design | 1 | 2011 | 154 | 0.020 |
Why?
|
| Pyruvate Oxidase | 1 | 2009 | 1 | 0.020 |
Why?
|
| Ear, Middle | 1 | 2009 | 2 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 376 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 871 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 44 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 222 | 0.020 |
Why?
|
| Reverse Transcription | 1 | 2009 | 16 | 0.020 |
Why?
|
| Brain | 2 | 2010 | 1268 | 0.020 |
Why?
|
| Astrocytes | 1 | 2010 | 203 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2009 | 145 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 1318 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2009 | 113 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 1124 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2009 | 123 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 555 | 0.020 |
Why?
|
| RNA | 1 | 2009 | 234 | 0.020 |
Why?
|
| Computational Biology | 1 | 2009 | 275 | 0.020 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2006 | 1 | 0.020 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2006 | 1 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 1961 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 1317 | 0.020 |
Why?
|
| Child | 1 | 2012 | 2875 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2004 | 2 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2004 | 4 | 0.020 |
Why?
|
| Virus Replication | 1 | 2006 | 261 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2004 | 43 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2003 | 2 | 0.020 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2003 | 16 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2003 | 53 | 0.020 |
Why?
|
| Transgenes | 1 | 2003 | 57 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 159 | 0.020 |
Why?
|
| beta 2-Microglobulin | 1 | 2003 | 8 | 0.010 |
Why?
|
| Antigens, CD1 | 1 | 2003 | 4 | 0.010 |
Why?
|
| Antigens, CD1d | 1 | 2003 | 5 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 92 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2003 | 55 | 0.010 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2003 | 3 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 25 | 0.010 |
Why?
|
| Hybridomas | 1 | 2003 | 28 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2003 | 77 | 0.010 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2002 | 2 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 391 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 252 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2003 | 306 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1490 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 9642 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 11034 | 0.010 |
Why?
|